Platelet Rich Plasma Versus Corticosteroids in Hip Osteoarthritis Pain

PHASE4RecruitingINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

February 21, 2024

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
Hip Osteoarthritis
Interventions
DEVICE

Platelet Rich Plasma Joint Injection

Magellan Autologous Concentration System, ISTO Biologics

DRUG

Corticosteroid Injection

5 milliliters (mL) injection of corticosteroid (1cc Kenalog, 4cc Xylocaine) Kenalog - 40 (triamcinolone acetonide injectable suspension, USP) Xylocaine - MPF (lidocaine HCl Injection, USP)

Trial Locations (1)

21215

RECRUITING

Sinai Hospital of Baltimore, Baltimore

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Hip Society

UNKNOWN

lead

LifeBridge Health

OTHER

NCT06793982 - Platelet Rich Plasma Versus Corticosteroids in Hip Osteoarthritis Pain | Biotech Hunter | Biotech Hunter